Explore Injective's newly launched research page for seamless access to technical papers, whitepapers, policy insights, and ...
In a recent announcement, Binance revealed its decision to remove and cease trading on five spot trading pairs on Dec. 26 at ...
21Shares has filed for a new spot Injective (INJ) ETF with the US Securities and Exchange Commission. The ETF issuer submitted the application on October 20, 2025, making Injective one of the altcoins ...
Pineapple Financial has launched a $100M Injective treasury, positioning itself as the first publicly traded INJ holder. The treasury will accumulate INJ tokens over the coming months, with plans to ...
Injective has joined a growing list of cryptocurrencies with a digital asset treasury amid an explosive corporate move on Wall Street. On Tuesday, Injective (INJ) announced that Wall Street firm ...
Pineapple Financial has launched the world’s first digital asset treasury for INJ. Injective price rose slightly amid the bullish news. ETFs and tokenization are also key catalyts for Injective.
Most crypto buyers know the frustration; chasing early gains, only to face long lockups, delayed launches, or projects that never deliver. The space is full of coins promising the moon but offering ...
Injective (INJ)is at the forefront of the real-world asset tokenization revolution, leveraging blockchain technology to offer innovative financial solutions and collaborations with major institutions.
Donald Trump’s inauguration is approaching, and many believe it could kick off the 2025 altcoin season. Tokens like Uniswap, Injective, and The Sandbox are expected to deliver significant returns.
Injective targets $33.34 and $50 after a bullish flag breakout, signaling strong momentum. Market sentiment remains bullish, with rising RSI, MA cross, and increasing Open Interest. Injective [INJ] ...
Injective (INJ) up 13% post-INJ 3.0 governance proposal (IIP-392) approval The IIP-392 proposal cuts INJ’s token supply, boosting its value Injective’s rise is further supported by the growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results